PHARMA LITERATI

Indian Council of Philosophical Research organizes Essay-Competition-cum Young Scholar’s Seminar on "The Idea of India". In order to encourage the Young Scholars of the country to reflect on Philosophical issues, the Council holds an Essay Competition-cum-seminar every year. This year, the theme of the Competition is “The Idea of India” . Young scholars in the age group of 20-25 years (born between 31.7.1990 to 31.7.1995) may send their essays typed in English or Hindi consisting of about 3000 words on one side of 21X30 cm. Size paper on the above theme. Topic:                                        The Idea of India. Last date for submission:           31 st July 2015.   Submissions to:                    The Programme Officer Academic Centre Indian Council of Philosophical Research 3/9, Vipul Khand, Gomti Nagar, Lucknow-226010. Prizes:                                         First Prize - Rs. 25,000 Second Prize - Rs. 20,000 Thir

Dear All, Every week of thousands of patent applications are published in India. The  patent applications filed by the pharma academic research institutes in India  go un-noticed. We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes. For details of these patents, please write back to us at  pharmaliterati@gmail.com Indian patent applications published on 24th April 2015 Invention Application No Inventors Institute Sustained release pharmaceutical compositions of Losartan potassium and Process for preparation thereof 907/MUM/2015 1)Pawar Harshal Ashok  2)Lalitha K.G. Not Known Formulation and evaluation of Itraconazole loaded Niosomal gel for the treatment of onychomycosis 3107/DEL/2013 1)Sahil Nagpal  2)D

Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, in collaboration with Maharashtra University of Health Sciences and Directorate of Medical Education & Research is introducing European Accredited Clinical Diabetes management for more than 5000 medical students in 18 medical colleges of Maharashtra University as part of Merck Capacity Advancement Program (CAP) in Asia.   The course is European accredited and will be incorporated in the MBBS curricula of 18 medical colleges. It is aimed to build up the future Diabetes health care capacity in Maharashtra. Prof. Dr Arun Jamkar, Vice Chancellor of Maharashtra University of Health Sciences, MUHS- Nashik emphasized" It gives us immense pleasure to invite the stakeholders in the field of medicine and diabetes in Maharashtra In joint collaboration with DMER and Merck, this Diabetes education course aims to provide guidelines and clinical practic

Indian Pharmaceutical Association is organizing its annual Convention this year in Mumbai at Hotel Trident, BKC, Mumbai.     The details are as follows: Theme:                    Indian Pharma Inc: Adapting to the Rapidly Evolving Global Challenges .            Dates:                      5th - 6th June 2015.   Organized by:           Indian Pharmaceutical Association.    Location:                   Mumbai.   Available at: http://www.ipapharma.org/events/IPA%20Convention%202015%201st%20Flyer.pdf The details would be posted soon on the website http://www.ipapharma.org/ .  

The Indian Drug Manufacturers’ Association and the above IDMA Subcommittees have pleasure in announcing the first Workshop of 2015 on ‘Laboratory Data Integrity’.   This workshop will allow the delegates to receive hands-on information regarding the “Do’s and Don’ts” of Data Integrity from experts in the field. At this workshop, Eminent Technical personnel from the Indian Pharmaceutical Industry, Research, Academic and Regulatory Affairs will converge and get together to interact on the various issues faced with regard to Laboratory Data Integrity .   The details are as follows: Theme:                        Workshop on Laboratory Data Integrity.            Dates:                           8th May 2015.   Organized by:            IDMA.    Location:                     Mumbai.   Details available at: http://www.idma-assn.org/

Indian Express reports that over 1000 stores selling generic medicines will be opened across India in June this year, when the government launches the scheme to provide affordable medicines, said Hansraj Ahir, Union Minister of State for Chemicals & Fertilizers on Monday.   “We are planning to launch in June….Over 1000 stores will be opened in the first month. We have a target of opening 3000 generic medicine shops during this year,” said Ahir who was in Ahmedabad to attend a workshop on Good Manufacturing Practices for the Indian Pharmaceutical manufacturers and state regulators.   “The government is also planning to rope in both the private sector and public sector units to help in providing uninterrupted supply of generic medicines to these new stores,” Ahir said adding that the government will start off with 504 medicines and then scale it over 670 medicines.   According to the minister, the government is ensuring that the new generic stores will be handed over to

Maha Darakshan discusses the hot debate in her article entitled "Generics versus Research" which can be accessed at http://www.risingkashmir.com/generics-versus-research/ .   The article focuses on the harsh realities in Indian Pharmaceutical market and the way the business is carried out. The debate as rightly pointed out by the author should be  primarily focused on ‘quality versus substandard’ pharmaceutical products.   Another article by Dr. Geer Mohammad Ishaq, Senior Assistant Professor, Department of Pharmaceutical Sciences, University of Kashmir is about generic drug prescribing, which can be accessed at http://www.greaterkashmir.com/news/2015/Apr/15/generic-drug-prescribing-7.asp   The article presents the current pharmacy practice in Kashmir. The highlight of the article is reproduced below: "It is saddening that even after fifteen years of formation of our own J&K Pharmacy Council which is not an offshoot of Pharmacy Council of India unlike

Pharma Times reports that n ew research suggests that pulsatile - or intermittent - dosing of statins might be effective enough to maintain an adequate cholesterol-lowering effect, while offering the advantages of boosting treatment compliance and cutting back National Health Service costs.   An analysis of UK GP prescribing and test records, sponsored by the SEEK Group, has shown that cholesterol levels remain below pre-statin levels for several months after patients stop taking them, raising hopes that their benefit could be reaped with just one week of dosing every three months instead of the current daily regime.     In the UK seven million people are currently taking statins to cut cholesterol, but treatment compliance and persistence is poor. Side effects include nosebleeds, sore throat, muscle weakness, problems with the digestive system, and an increased risk of diabetes, and more than 50% of patients stop their statin therapy within a year, worsening treatment outco

Responding to the requirement of pharmaceutical industry and the recent development in pharma education, healthcare research institutions of the country, The  IIHMR (Indian Institute of Health Management and Research)  University invites applications for  MBA in Pharmaceutical Management. As per Mc Kinsey report-India Pharma 2015 – Unlocking the Potential of the Indian Pharmaceutical Market, the pharma industry has immense opportunities and has a  projected market growth of USD 24 billion by 2015 and USD 55 billion by 2020.  The hospital segment will increase its share and influence, growing to 25 per cent of the market in 2020. Forecasting the growth factors and the employment opportunities that will rise to over 4 million by 2025,  As per the PwC study Indian Pharma Inc. the industry is likely to be in the top ten global markets in value terms by 2020.” There is a growing need of talent pool and it is indeed a growing challenge for the academia, to transform the students in